Median Technologies SA (ALMDT):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Median Technologies SA (ALMDT) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C6374
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:45
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フランス
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Median Technologies SA (Median) is a medical technology company that develops and markets medical imaging solutions. The company offers clinical trials, imaging services for CT, scientific consulting, image and clinical data management, image data processing and site support, managed services and investigator site network services. Its imaging services include regulations compliance, project management, data management and quality control, biostatistics and data analysis, and IT services. Median’s clinical trial services comprise imaging protocol design, site training and management, radiological review, imaging biomarkers, image analysis and reporting, and others. The company develops iBiopsy, a phenomics platform designed to acquire, index, and analyze individual phenotypes. It markets its solutions to pharmaceutical companies, healthcare institutions, hospitals, and cancer clinics. The company has operations in France and the US. Median is headquartered in Valbonne, France.

Median Technologies SA (ALMDT) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Median Technologies SA, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Median Technologies SA, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Median Technologies SA, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Median Technologies SA, Medical Equipment, Deals By Market, 2012 to YTD 2018 9
Median Technologies SA, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Median Technologies SA, Medical Equipment, Deal Details 11
Venture Financing 11
MEDIAN Technologies Secures USD0.67 Million in Venture Funding 11
Partnerships 12
Median Technologies Enters into Agreement with Nice University 12
Median Technologies Enters into Research Agreement with Xingtai People’s Hospital 13
Median Technologies Partners with Microsoft 14
Median Technologies Partners with START 15
Equity Offering 16
Median Technologies Raises USD21.8 Million in Private Placement of Shares 16
Median Technologies Raises USD22 Million in Private Placement of Shares 17
Median Technologies Raises USD26.5 Million in Private Placement of Units 19
Median Technologies SA – Key Competitors 21
Median Technologies SA – Key Employees 22
Median Technologies SA – Locations And Subsidiaries 23
Head Office 23
Other Locations & Subsidiaries 23
Recent Developments 24
Strategy And Business Planning 24
Mar 12, 2018: Median Technologies and the Nice University Hospital (CHU De Nice) Announce Agreement to Advance Lung Cancer Screening with Artificial Intelligence 24
Jun 22, 2017: Median Technologies and Medidata Partner to Deliver Differentiated Image Management Services in Clinical Trials 25
Financial Announcements 26
Feb 21, 2018: Median Technologies Announces Preliminary Full Year 2017 Unaudited Financial Results 26
Oct 10, 2017: Median Technologies: H1 2017 results: half-year marked by major investments to structure the company and prepare for the future 27
Apr 12, 2017: Median Technologies Reports Full Year 2016 Financial Results 29
Corporate Communications 31
Jul 12, 2018: Median Technologies Receives the Forbes 2018 Futur40 Award and Special Recognition Prize for the “Health-Life Sciences” Company Category 31
May 24, 2018: Median Technologies Appoints Dr. Yan Liu as Medical Director, Europe 32
Nov 09, 2017: Median Technologies Appoints Dr. Peter Bannister as Chief Technology Officer 33
Oct 26, 2017: Median Technologies strengthens its medical leadership with the appointment of Dr. Loan Hoang-Sayag as Chief Medical Officer and the appointment of Dr. Fabien Ricard as Medical Director, North America 34
Oct 19, 2017: Median Technologies Appoints Vivian Wang as General Manager, China and Takashi Hayashi as Managing Director, Japan 35
Product News 36
Dec 14, 2017: Median Technologies Launches iSee- a Comprehensive Technology Platform to Enhance Medical Imaging Analysis in Clinical Trials 36
Nov 14, 2017: Median Technologies to Present at Medidata NEXT Global 2017 to Discuss How New Technologies Can Optimize Image Management in Clinical Trial 37
Nov 07, 2017: Median Technologies to Present at Medidata NEXT Global 2017 to Discuss How New Technologies Can Optimize Image Management in Clinical Trials 38
Oct 17, 2017: Median Technologies to Attend The Liver Meeting of The American Association for the Study of Liver Diseases to Be Held October 20-24, 2017 in Washington, DC, USA 39
Sep 06, 2017: Median Technologies to Attend the ESMO 2017 Congress, September 8-12, 2017, Madrid, Spain 40
May 31, 2017: Median Technologies to attend the 2017 ASCO Annual Meeting, June 2-6, 2017, McCormick Place, Chicago, IL, USA 41
Other Significant Developments 42
Apr 26, 2018: Median Technologies launches ImageBank 42
Nov 28, 2017: Median Technologies inks a collaboration agreement with Memorial Sloan Kettering Cancer Center for a study dealing with prostate cancer 43
Oct 31, 2017: Median Technologies adds MediScan to its product portfolio 44
Appendix 45
Methodology 45
About GlobalData 45
Contact Us 45
Disclaimer 45

List of Tables
Median Technologies SA, Medical Equipment, Key Facts, 2017 2
Median Technologies SA, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Median Technologies SA, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Median Technologies SA, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Median Technologies SA, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Median Technologies SA, Deals By Market, 2012 to YTD 2018 9
Median Technologies SA, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
MEDIAN Technologies Secures USD0.67 Million in Venture Funding 11
Median Technologies Enters into Agreement with Nice University 12
Median Technologies Enters into Research Agreement with Xingtai People’s Hospital 13
Median Technologies Partners with Microsoft 14
Median Technologies Partners with START 15
Median Technologies Raises USD21.8 Million in Private Placement of Shares 16
Median Technologies Raises USD22 Million in Private Placement of Shares 17
Median Technologies Raises USD26.5 Million in Private Placement of Units 19
Median Technologies SA, Key Competitors 21
Median Technologies SA, Key Employees 22
Median Technologies SA, Other Locations 23
Median Technologies SA, Subsidiaries 23

List of Figures
Median Technologies SA, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Median Technologies SA, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Median Technologies SA, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Median Technologies SA, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Median Technologies SA, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Median Technologies SA, Medical Equipment, Deals by Type, 2012 to YTD 2018 7
Median Technologies SA, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Median Technologies SA, Medical Equipment, Deals by Market, 2012 to YTD 2018 9

★海外企業調査レポート[Median Technologies SA (ALMDT):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Petrogrand AB:石油・ガス:M&Aディール及び事業提携情報
    Summary Petrogrand AB (Petrogrand), formerly Malka Oil AB is an oil and gas company that acquires, explores and produces crude oil and natural gas assets. The company carries out management and refining of Russian oil assets. It holds interests in the Nizhne-Paninsky license area located in northwes …
  • PetSmart Inc:企業の戦略・SWOT・財務分析
    PetSmart Inc - Strategy, SWOT and Corporate Finance Report Summary PetSmart Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • EnergyAustralia Pty Ltd:電力:M&Aディール及び事業提携情報
    Summary EnergyAustralia Pty Ltd (EnergyAustralia), formerly TRUenergy, is an electric utility that invests in energy generation and retailing activities. The company generates electricity and retails power and gas. It produces electricity from coal, gas, solar and wind sources. EnergyAustralia offer …
  • Patel Engineering Ltd
    Patel Engineering Ltd - Strategy, SWOT and Corporate Finance Report Summary Patel Engineering Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Netsmart Technologies Inc:企業の戦略的SWOT分析
    Netsmart Technologies Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Vienna Insurance Group AG:企業の戦略・SWOT・財務情報
    Vienna Insurance Group AG - Strategy, SWOT and Corporate Finance Report Summary Vienna Insurance Group AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Radico Khaitan Ltd.:企業の戦略・SWOT・財務分析
    Radico Khaitan Ltd. - Strategy, SWOT and Corporate Finance Report Summary Radico Khaitan Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • WellCare Health Plans Inc (WCG):製薬・医療:M&Aディール及び事業提携情報
    Summary WellCare Health Plans Inc (WellCare) is a managed care services provider which focuses on providing government-sponsored managed care services to families, children, seniors and individuals with complex medical needs. The company offers Medicaid health plans, Medicare Advantage (MA) coordina …
  • Kimball International, Inc. (KBAL):企業の財務・戦略的SWOT分析
    Kimball International, Inc. (KBAL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Denka Co Ltd (4061):企業の財務・戦略的SWOT分析
    Denka Co Ltd (4061) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • TiGenix NV (TIG):企業の財務・戦略的SWOT分析
    Summary TiGenix NV (TiGenix), a subsidiary of Takeda Pharmaceutical Co Ltd, is a biopharmaceutical company that develops and commercializes novel therapeutic products. The company exploits the anti-inflammatory properties of stem cells to develop novel therapies. It offers products such as AlloCSC-0 …
  • Societe BIC (BB):企業の財務・戦略的SWOT分析
    Societe BIC (BB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • bebe stores, inc.:企業の戦略・SWOT・財務分析
    bebe stores, inc. - Strategy, SWOT and Corporate Finance Report Summary bebe stores, inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • MetaStat Inc (MTST):医療機器:M&Aディール及び事業提携情報
    Summary MetaStat Inc (MetaStat) is a biotechnology company that discovers and develops personalized diagnostic and therapeutic treatment solutions for cancer patients. The company develops therapeutic product candidates based on novel approach that offers intracellular Mena protein isoforms drugable …
  • Escalier Biosciences BV:製薬・医療:M&Aディール及び事業提携情報
    Summary Escalier Biosciences BV (Escalier Biosciences) is a biopharmaceutical company, which develops small molecule medicines for the treatment of autoimmune disorders. Its pipeline products include topical and oral RAR-related orphan receptor gamma inverse agonists. Inhibition of RAR-related orpha …
  • Discovery Inc (DISCA):企業の財務・戦略的SWOT分析
    Discovery Inc (DISCA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Pharmacyclics LLC:企業の戦略的SWOT分析
    Pharmacyclics LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Healthsense Inc:医療機器:M&Aディール及び事業提携情報
    Summary Healthsense Inc (Healthsense), a subsidiary of GreatCall Inc is a medical device company that provides remote monitoring services. The company offers technology-enabled care solutions, aging technology services, for the entire senior care continuum. Its products include eNeighbor remote moni …
  • Eidgenossische Technische Hochschule Zurich-医療機器分野:企業M&A・提携分析
    Summary Eidgenossische Technische Hochschule Zurich(ETH Zurich) is an educational university that offers studies in technology and the natural sciences. The university provides scientific education through bachelor programmes and master programmes in the areas of applied geophysics, architecture, bi …
  • Alexion Pharmaceuticals Inc (ALXN):製薬・医療:M&Aディール及び事業提携情報
    Summary Alexion Pharmaceuticals Inc (Alexion) focuses on developing and delivering life-changing drug therapies for patients with serious and ultra-rare disorders. The company develops biologic therapeutic products for the treatment of severe disease states, including genetic diseases, hematologic d …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆